LC-MS/MS Profiling of Blood Serum Reveals Disease-Enriched Peptides in Metabolic Syndrome
Journal of Personalized Medicine · 11.08.2026 · 16 (8) · 425
DOI: 10.3390/jpm16080425 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Personalized Medicine, online erschienen am 11.08.2026. Verfasst von Alma Nurtazina und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, Semey Medical University, 071400 Semey, Kazakhstan. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Republic of Kazakhstan, Russian Science Foundation.
Abstract (Originalsprache)
Background
Metabolic syndrome (MetS) is a heterogeneous cardiometabolic group of conditions in which early disturbances of glucose homeostasis are not always adequately captured by routine clinical tests.
Methods
In this pilot study, liquid chromatography–tandem mass spectrometry (LC-MS/MS)-based blood serum peptidomics was applied to identify circulating peptide signatures associated with MetS and progressive glycemic impairment. Serum samples from healthy donors and patients with MetS, including subgroups with normoglycemia, prediabetes, and diabetes mellitus, were subjected to peptide enrichment by ultrafiltration and solid-phase extraction prior to LC-MS/MS analysis.
Results
Overall, 6754 unique peptides derived from 1820 precursor proteins were identified, and 32 peptides were significantly overrepresented in patients with MetS relative to healthy donors. Eight precursor proteins and five identified peptides showed significant positive correlations with glycemic stage, likely indicating progressive remodeling of the circulating serum peptidome during disease progression. A separate analysis of patients with prediabetes revealed additional candidate markers associated with early metabolic alterations. Moreover, multivariate logistic regression identified a four-peptide panel with good discriminatory performance for differentiating healthy donors from patients with MetS, yielding a leave-one-out cross-validated area under the curve of 0.91.
Conclusions
Collectively, these findings indicate that serum peptidome profiling can reveal biologically and clinically relevant possible candidate biomarkers associated with MetS and early dysglycemia.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology and Biostatistics, Semey Medical University, 071400 Semey, Kazakhstan.
- Outpatient Clinic #1, Department of Internal Medicine and Cardiology, Semey Medical University, 071400 Semey, Kazakhstan.
- Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia.
- Center for Molecular and Cellular Biology, 121205 Moscow, Russia.
- Faculty of Biology and Biotechnology, Al-Farabi Kazakh National University, 050040 Almaty, Kazakhstan.
- Kazakhstan-Japan Innovative Center, Kazakh National Agrarian Research University, 050010 Almaty, Kazakhstan.
ORCID-Profile: Alma Nurtazina, Maxat Toishimanov, Victoria Shender, Georgij Arapidi
Förderung
- Ministry of Science and Higher Education of the Republic of Kazakhstan
- Russian Science Foundation
Zitieren
APA
Nurtazina, A., Koss, V., Voitsekhovskiy, I., Toishimanov, M., Dautov, D., Karibayev, K., Shender, V., & Arapidi, G. (2026). LC-MS/MS Profiling of Blood Serum Reveals Disease-Enriched Peptides in Metabolic Syndrome. Journal of Personalized Medicine, 16(8), 425. https://doi.org/10.3390/jpm16080425
Vancouver
Nurtazina A, Koss V, Voitsekhovskiy I, Toishimanov M, Dautov D, Karibayev K, et al. LC-MS/MS Profiling of Blood Serum Reveals Disease-Enriched Peptides in Metabolic Syndrome. Journal of Personalized Medicine. 2026;16(8):425. doi:10.3390/jpm16080425
BibTeX
@article{Nurtazina2026,
author = {Nurtazina, Alma and Koss, Valeriia and Voitsekhovskiy, Ivan and Toishimanov, Maxat and Dautov, Daulet and Karibayev, Kairat and Shender, Victoria and Arapidi, Georgij},
title = {LC-MS/MS Profiling of Blood Serum Reveals Disease-Enriched Peptides in Metabolic Syndrome},
journal = {Journal of Personalized Medicine},
year = {2026},
volume = {16},
number = {8},
pages = {425},
doi = {10.3390/jpm16080425}
}
EUVIMED